On June 13, 2018 Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, reported that it will participate in a panel and host investor meetings at the JMP Securities Life Sciences Conference in New York on Wednesday, June 20, 2018 (Press release, Editas Medicine, JUN 13, 2018, View Source;p=RssLanding&cat=news&id=2354406 [SID1234527295]). Details of the panel are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Panel: Gene Editing – From Science to Reality
Date: Wednesday, June 20, 2018
Time: 8:00 a.m.
Location: St. Regis Hotel, New York